Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramlintide acetate injection adjunct to insulin in type 2 diabetes (Phase III, China)
CTR20131804Phase 3Completed
- Sponsor
- Hainan Zhonghe Pharmaceutical
- Start
- Mar 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of pramlintide in type 2 diabetes mellitus (T2DM), sponsored by Hainan Zhonghe Pharmaceutical. Started Mar 2014; status: completed.
02
Drugs
pramlintide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20131804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131804.